AstraZeneca faces legal battles over rare side effects of its COVID-19 vaccine, revealing a shocking admission.
AstraZeneca, the pharmaceutical giant behind the popular COVID-19 vaccine, is currently embroiled in legal battles as 51 lawsuits, totaling around ยฃ100 million in damages, have been filed against the company. These lawsuits stem from rare side effects of the AstraZeneca vaccine, specifically a deadly blood-clotting condition known as Thrombosis Thrombocytopenia Syndrome (TTS). In a recent court filing, AstraZeneca openly acknowledged the potential risk of TTS associated with their vaccine, sparking concerns among both medical professionals and the public.
India Today engaged with healthcare experts to discuss AstraZeneca's confession and the implications of TTS triggered by their COVID-19 vaccine. The admission by AstraZeneca has raised significant questions about the safety and efficacy of the vaccine, leading to a reassessment of its usage in various countries. Despite the acknowledgment of rare side effects, AstraZeneca's vaccine remains a crucial element in the global vaccination drive against the ongoing pandemic.
In the midst of mounting legal challenges and public scrutiny, AstraZeneca continues to face backlash for downplaying the risks associated with their COVID-19 vaccine. The company's submission in a UK court highlighted the potential dangers of blood clotting syndrome linked to the vaccine. Doctors in India, however, have long been aware of this risk and are navigating the delicate balance between the benefits of vaccination and the rare but serious side effects that may arise.
AstraZeneca's acknowledgment of the rare blood clot risk associated with their COVID-19 jabs has heightened concerns among the public, emphasizing the importance of transparent communication and thorough assessment of vaccine safety. As the debate around vaccine risks and benefits continues, medical professionals and regulatory bodies strive to ensure that the benefits of vaccination outweigh the potential dangers, promoting trust and confidence in the global vaccination efforts.
51 lawsuits have been filed against AstraZeneca, with victims and bereaved families seeking compensation for damages totaling an estimated ยฃ100m...
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition.
India Today spoke to doctors about AstraZeneca's admission and the rare side effect called TTS triggered by its Covid-19 vaccine.
Pharmaceutical giant AstraZeneca, in a damning revelation, has admitted that its Covid-19 vaccine 'Covishield' can, in "very rare cases, cause TTS".
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the ...
AstraZeneca's COVID-19 vaccine may cause rare blood clotting syndrome, but doctors in India are well aware of the risk.
Facing a class action lawsuit in the UK, the drug company acknowledged a rare blood clotting risk from covid jabs.
This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare ...
AstraZeneca admits Covishield's rare side effect TTS, causing blood clots with low platelets. TTS symptoms include severe headaches, abdominal pain. T.
AstraZeneca reaffirms commitment to patient safety and safety profile of vaccines amid concerns over rare side effects of COVID-19 vaccine.
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its ...
Gujarat Congress president Shaktisinh Gohil also questioned the government's choice of the Serum Institute for vaccine production instead of the Central ...